Cargando…
RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
BACKGROUND: Inhibition of p38 MAPK signalling leads to glioblastoma multiform (GBM) tumourigenesis. Nevertheless, the molecular mechanism that induces p38 MAPK signalling pathway silencing during GBM genesis has yet to be determined. Identifying new factors that can regulate p38 MAPK signalling is i...
Autores principales: | Xu, Yang, Sun, Qian, Yuan, Fan’en, Dong, Huimin, Zhang, Huikai, Geng, Rongxin, Qi, Yangzhi, Xiong, Xiaoxing, Chen, Qianxue, Liu, Baohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457501/ https://www.ncbi.nlm.nih.gov/pubmed/32867814 http://dx.doi.org/10.1186/s13046-020-01671-2 |
Ejemplares similares
-
Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma
por: Sun, Qian, et al.
Publicado: (2022) -
Small GTPase RHOE/RND3, a new critical regulator of NF‐κB signalling in glioblastoma multiforme?
por: Sun, Qian, et al.
Publicado: (2019) -
SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling
por: Zhang, Huikai, et al.
Publicado: (2021) -
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019) -
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)